Immune cell therapy for advanced liver cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new therapy made from your own immune cells (called TILs). The cells are taken from your tumor, multiplied in a lab, and given back to you to help your body fight the cancer. It's an early study to see if it's safe and if it can shrink liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have liver cancer that has spread or cannot be removed with surgery, and standard treatments have not worked or you could not take them.
- You have a tumor that can be removed for this study (at least 8 cubic centimeters).
- You are generally healthy enough for daily activities (ECOG score of 0 or 1).
- Your liver and kidney function are within acceptable levels, and your heart and lungs are working well.
- You have not had certain treatments or surgeries within the past few weeks before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests engineered immune cells (TILs/CAR-TILs) made from your tumor to treat advanced solid cancers that have not responded to standard treatments. It may help your immune system better recognize and attack the cancer, but it is mainly focused on safety and early results.
This trial tests a new cell therapy called BST08, made from your own immune cells, for advanced non-small cell lung cancer that has not responded to at least two standard treatments. The goal is to see if this therapy is safe and can help shrink tumors.
This trial tests a new treatment using your own immune cells (tumor-infiltrating lymphocytes) to fight advanced liver cancer. It is for people whose cancer has progressed after at least two standard treatments and who have tumors that can be biopsied to grow these cells.
This trial studies an experimental cell therapy that uses your own immune cells collected from your tumor to fight the cancer. It aims to see if this approach is safe and effective for advanced liver cancer that has progressed after standard treatments.
This trial studies a treatment called TIL therapy, which uses your own immune cells grown from a tumor sample, to treat advanced cancers of the liver/bile ducts or pancreas. It’s mainly for people whose standard treatments have already failed (or none exist), and who can safely provide tumor tissue for the cell preparation.
This study tests a new treatment using your body's own immune cells (called tumor-infiltrating lymphocytes) that are taken from your tumor, grown in a lab, and then put back into you. It's for people with advanced solid tumors who have run out of standard options.
Hear when a new Locally Advanced/Metastatic Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.